Product
romidepsin
1 clinical trial
11 indications
Indication
Nasal Type Extranodal NK/T-cell LymphomaIndication
Anaplastic Large Cell LymphomaIndication
Angioimmunoblastic T-cell LymphomaIndication
Hepatosplenic T-cell LymphomaIndication
Peripheral T-cell LymphomaIndication
Cutaneous T-cell Non-Hodgkin LymphomaIndication
Mycosis Fungoides/Sezary SyndromeIndication
Cutaneous T-cell non-Hodgkin lymphomaIndication
Mycosis Fungoides and Sezary SyndromeClinical trial
Phase II Study of Romidepsin Plus Lenalidomide for Patients With Previously Untreated PTCLStatus: Active (not recruiting), Estimated PCD: 2020-08-11